Jennifer Bath | CEO |
Barry Duplantis | VP-Client Relations |
Ilse Roodink | Chief Scientific Officer |
Brad McConn | CFO |
Will McHale | Ingalls & Snyder |
Ramakanth Swayampakula | H.C. Wainwright |
Michael Freeman | Raymond James |
Good morning, ladies and gentlemen. Thank you for joining us today for IPA's earnings call covering the fourth quarter and full fiscal year of 2023. I am Regina, and I have the privilege of hosting this call.
Before we commence, I would like to draw your attention to the fact that our discussion today may include forward-looking statements. These statements are subject to various risks and uncertainties that could cause actual results to differ materially from what we express or imply.